Editorial: Novel and Improved Methods for the Prevention and Treatment of Graft-Versus-Host Disease (GVHD)

Evelyn Ullrich; Andreas Beilhack; Dietlinde Wolf

doi:10.3389/fimmu.2022.966389

Editorial: Novel and Improved Methods for the Prevention and Treatment of Graft-Versus-Host Disease (GVHD)

Front Immunol. 2022 Jun 30:13:966389. doi: 10.3389/fimmu.2022.966389. eCollection 2022.

Authors

Evelyn Ullrich^{1

2

3}, Andreas Beilhack⁴, Dietlinde Wolf⁵

Affiliations

¹ Experimental Immunology, Children's University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
² Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt am Main, Germany.
³ German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt am Main, Germany.
⁴ Department of Medicine II, Center for Interdisciplinary Clinical Research (IZKF), University Hospital Wuerzburg, Wuerzburg, Germany.
⁵ Sylvester Comprehensive Cancer Center; University of Miami, Miller School of Medicine, Miami, FL, United States.

No abstract available

Keywords: GVL; acute and chronic graft versus host disease (a/c GVHD); allogeneic hematopoietic stem cell transplantation (aHSCT); cell therapy; metabolism; microbiome.

Publication types

Editorial

MeSH terms

Graft vs Host Disease* / prevention & control
Graft vs Leukemia Effect
Humans
Transplantation, Homologous / adverse effects